Search research articles
Contact Us
Filters
Showing results (41-50 of 122) with videos related to
Page
of 13
Sort By:
The Cochrane Database of Systematic Reviews
|
December 2, 2024
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphoma
Marius Goldkuhle, Nina Kreuzberger, Bastian von Tresckow, et al.
Annals of Hematology
|
March 28, 2024
Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians
Cordula Gebel, Isabel Kruschel, Steffi Bodinger, et al.
Leukemia & Lymphoma
|
May 18, 2016
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation
Bastian von Tresckow, Franck Morschhauser, Jeffrey Szer, et al.
Leukemia & Lymphoma
|
December 5, 2025
Characteristics, patterns of care and outcomes of patients with T-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysis
Till Braun, Maren Keppel, Annika Dechow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group
Beate Klimm, Jeremy Franklin, Harald Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2015
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials
Heinz Haverkamp, Boris Böll, Dennis A Eichenauer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 13, 2021
[Update 2021: COVID-19 from the perspective of intensive care]
Stephanie-Susanne Stecher, Hans Joachim Stemmler, Dennis A Eichenauer, et al.
Blood
|
August 2, 2018
Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
Dennis A Eichenauer, Annette Plütschow, Lena Schröder, et al.
Leukemia
|
October 23, 2019
Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group
Dennis A Eichenauer, Annette Plütschow, Michael Fuchs, et al.
Blood
|
August 11, 2011
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
Dennis A Eichenauer, Michael Fuchs, Annette Pluetschow, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 122) with videos related to
Sort By:
Page
of 13
The Cochrane Database of Systematic Reviews
|
December 2, 2024
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphoma
Marius Goldkuhle, Nina Kreuzberger, Bastian von Tresckow, et al.
Annals of Hematology
|
March 28, 2024
Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians
Cordula Gebel, Isabel Kruschel, Steffi Bodinger, et al.
Leukemia & Lymphoma
|
May 18, 2016
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation
Bastian von Tresckow, Franck Morschhauser, Jeffrey Szer, et al.
Leukemia & Lymphoma
|
December 5, 2025
Characteristics, patterns of care and outcomes of patients with T-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysis
Till Braun, Maren Keppel, Annika Dechow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group
Beate Klimm, Jeremy Franklin, Harald Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2015
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials
Heinz Haverkamp, Boris Böll, Dennis A Eichenauer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 13, 2021
[Update 2021: COVID-19 from the perspective of intensive care]
Stephanie-Susanne Stecher, Hans Joachim Stemmler, Dennis A Eichenauer, et al.
Blood
|
August 2, 2018
Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
Dennis A Eichenauer, Annette Plütschow, Lena Schröder, et al.
Leukemia
|
October 23, 2019
Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group
Dennis A Eichenauer, Annette Plütschow, Michael Fuchs, et al.
Blood
|
August 11, 2011
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
Dennis A Eichenauer, Michael Fuchs, Annette Pluetschow, et al.
Page
of 13